Geneo Logo
Geneo
AI Visibility Report
12/15/2025
Live Analysis:
ChatGPT_

AI Visibility Report for
nutraceuticalvspharmaceuticalregulations

Are you in the answers when your customers ask AI?

Enter your prompt and find out which brands dominate AI search results.

Free Report
No Signup
Brand Performance Across AI Platforms
All 6 brands referenced across AI platforms for this prompt
FDA
8
0
Sentiment:
Score:95
Atlantiaclinicaltrials
4
1
Sentiment:
Score:79
Nutraceutical Business Review
2
1
Sentiment:
Score:68
4EFSA
2
0
Sentiment:
Score:61
5Foodsafety Institute
0
1
Sentiment:
Score:56
Referenced Domains Analysis
All 13 domains referenced across AI platforms for this prompt
ChatGPT
Perplexity
Google AIO
#1geneo.app favicongeneo.app
ChatGPT:
0
Perplexity:
1
Google AIO:
0
1
#2wbcil.com faviconwbcil.com
ChatGPT:
0
Perplexity:
1
Google AIO:
0
1
#3colorcon.com faviconcolorcon.com
ChatGPT:
0
Perplexity:
1
Google AIO:
0
1
#4peoriapros.com faviconpeoriapros.com
ChatGPT:
0
Perplexity:
1
Google AIO:
0
1
#5pharmanow.live faviconpharmanow.live
ChatGPT:
0
Perplexity:
1
Google AIO:
0
1

AI Search Engine Responses

Compare how different AI search engines respond to this query

ChatGPT

4098 Characters

BRAND (6)

FDA
EMA
EFSA
Nutraceutical Business Review
Atlantiaclinicaltrials
Foodsafety Institute

SUMMARY

ChatGPT provides a comprehensive educational overview comparing nutraceuticals and pharmaceuticals, starting with clear definitions and purposes. It explains that nutraceuticals are food-derived products offering health benefits beyond nutrition, while pharmaceuticals are substances for diagnosing, treating, or preventing diseases. The response begins to detail regulatory frameworks, focusing on the United States system and mentioning how nutraceuticals and pharmaceuticals differ in their regulatory requirements and approval processes.

Perplexity

3496 Characters

BRAND (6)

FDA
EMA
EFSA
Nutraceutical Business Review
Atlantiaclinicaltrials
Foodsafety Institute

SUMMARY

Perplexity delivers a technical analysis focusing specifically on regulatory differences between nutraceuticals and pharmaceuticals. It emphasizes that nutraceuticals face much less stringent regulation, requiring no FDA pre-market approval or efficacy proof, relying instead on manufacturer responsibility and post-market enforcement. The response contrasts this with pharmaceuticals' formal pre-market authorization requirements, including clinical trials for safety and efficacy demonstration, and mentions DSHEA (1994) as the primary statute governing nutraceuticals.

Google AIO

0 Characters

BRAND (6)

FDA
EMA
EFSA
Nutraceutical Business Review
Atlantiaclinicaltrials
Foodsafety Institute

SUMMARY

No summary available.

Strategic Insights & Recommendations

Dominant Brand

FDA dominates the regulatory discussion across platforms, being the primary authority referenced for both nutraceutical and pharmaceutical oversight.

Platform Gap

ChatGPT provides broader educational context while Perplexity focuses specifically on technical regulatory differences, with Google AIO providing no response.

Link Opportunity

Perplexity's higher link count (10 vs 3) suggests stronger source attribution and potential for authoritative content linking in regulatory discussions.

Key Takeaways for This Prompt

Regulatory agencies like FDA are consistently referenced as the primary authorities in nutraceutical vs pharmaceutical discussions.

Technical regulatory content performs well on Perplexity while educational overviews suit ChatGPT's format better.

The absence of Google AIO response indicates potential content gap opportunity for comprehensive regulatory comparison content.

DSHEA (1994) and clinical trial requirements represent key differentiating factors that platforms emphasize in regulatory discussions.

Share Report

Share this AI visibility analysis report with others through social media